Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. ESMO Gastrointestinal Cancers Congress 2024
  5. ESMO Gastrointestinal Cancers Congress 2024 Satellites Symposia

F. Hoffmann-La Roche Ltd. - Innovating for patients today and in the future: Advancing therapies for hepatocellular carcinoma

What are the main opportunities in HCC treatment today?

Date

28 Jun 2024

Session

F. Hoffmann-La Roche Ltd. - Innovating for patients today and in the future: Advancing therapies for hepatocellular carcinoma

Presenters

Lorenza Rimassa

Authors

L. Rimassa1, D.J. Pinato2, B. Zovich3

Author affiliations

  • 1 Humanitas Cancer Center, IRCCS Humanitas Research Hospital; Humanitas University, Rozzano/IT
  • 2 Imperial College London - Hammersmith Hospital, London/GB
  • 3 Hepatitis B Foundation, 18902 - Doylestown/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and introduction

Presenter: Lorenza Rimassa

Session: F. Hoffmann-La Roche Ltd. - Innovating for patients today and in the future: Advancing therapies for hepatocellular carcinoma

Resources:

Webcast

Q&A

Presenter: Lorenza Rimassa

Session: F. Hoffmann-La Roche Ltd. - Innovating for patients today and in the future: Advancing therapies for hepatocellular carcinoma

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.